Antioxidant defence-related genetic variants are not associated with higher risk of secondary thyroid cancer after treatment of malignancy in childhood or adolescence
Vodusek, Ana Lina, Goricar, Katja, Gazic, Barbara, Dolzan, Vita, Jazbec, Janez
Clinical outcomes in stage III non-small cell lung cancer patients treated with durvalumab after sequential or concurrent platinum-based chemoradiotherapy – single institute experience
Vrankar, Martina, Stanic, Karmen, Jelercic, Stasa, Ciric, Eva, Vodusek, Ana Lina, But-Hadzic, Jasna